Medication info
Lipiclin Tablets 20 mg (Atorvastatin Calcium Trihydrate)

Lipiclin Tablets 20 mg (Atorvastatin Calcium Trihydrate)

Prescription medicationTablet
Ingredient · strength
Atorvastatin Calcium Trihydrate›21.7mg / 1 tablet
Manufacturer / importer
EnBK Pharmaceutical Co., Ltd.
Appearance
White round film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 201708496 · Approved 2017.12.21 · Insurance code 054800070

Summary

Main use
Improvement of hyperlipidemia in adults and children; prevention of cardiovascular diseases (including myocardial infarction and stroke)
Who uses it
Adults · Children
Adult dosage
Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (the 40 mg starting dose is for patients requiring an LDL cholesterol reduction of 45 % or greater). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.
Children's dosage
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug above 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the treatment goal recommended for each patient. Adjust the dose at intervals of 4 weeks or longer.

Ingredients

Manufacturer
EnBK Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia in adults and children; prevention of cardiovascular diseases (including myocardial infarction and stroke)

  • Coronary heart disease
  • myocardial infarction
  • stroke
  • chronic stable angina
  • retinopathy
  • albuminuria
  • congestive heart failure
  • hyperlipidemia
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • abnormal beta-lipoproteinemia
  • elevated serum triglycerides
View approved original text

This medication helps adult and pediatric patients with various risk factors related to cardiovascular diseases. In particular, it reduces the risk of serious cardiovascular events, such as myocardial infarction or stroke, and is used for improving the condition of patients undergoing vascular surgery and those with angina pectoris. It also serves as an adjunct therapy for patients with hyperlipidemia or dyslipidemia that is difficult to control with diet alone, effectively lowering total cholesterol, LDL cholesterol, and triglyceride levels while increasing levels of good cholesterol, HDL. It is safe for pediatric patients with familial hypercholesterolemia aged 10 to 17 years, helping to lower the risk of cardiovascular diseases. Overall, this medication is used to improve cardiovascular health and blood lipid levels.

Dosage and Administration

Adult dosage

Patients should follow a standard cholesterol-lowering diet before and during treatment with atorvastatin. This drug may be taken at any time of day, with or without food. 1. Hyperlipidemia The recommended initial dose is 10 mg of atorvastatin once daily. However, patients requiring a greater reduction in LDL cholesterol may start with 20 mg or 40 mg once daily (the 40 mg starting dose is for patients requiring an LDL cholesterol reduction of 45 % or greater). This drug is administered in a dose range of 10 ~ 80 mg once daily. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Because the goal of treatment is to lower LDL cholesterol, it is recommended that LDL cholesterol be used when initiating treatment and evaluating the response. However, if LDL cholesterol levels are unavailable, total cholesterol should be used to monitor the treatment response. Patients with homozygous familial hypercholesterolemia The dose of this drug is 10 ~ 80 mg once daily. Administer it in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. ○ Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, dose adjustment is not necessary. ○ Older adults: The efficacy and safety in patients aged 70 years or older are similar to those in the general adult patient population.

Children's dosage

Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this drug once daily, and the recommended maximum dose is 20 mg daily (there are no clinical data on doses of this drug above 20 mg in pediatric patients). The dose should be adjusted as appropriate according to the treatment goal recommended for each patient. Adjust the dose at intervals of 4 weeks or longer.

Precautions

This medication may cause muscle-related adverse effects; if severe muscle pain or weakness occurs or if creatine kinase levels rise significantly, discontinue use immediately and consult a physician. Particularly, patients with serious infections, hypotension, prior major surgery or trauma, or liver or kidney dysfunction may need to temporarily pause or stop treatment. Patients with a history of allergic reactions to this medication, active liver disease, severe muscle disorders, those who are pregnant or nursing, children under 10 years, and patients taking certain medications should not use it. Patients with alcoholism, a history of liver disease, impaired kidney function, hypothyroidism, and elderly patients, who are at higher risk of muscle damage, require careful evaluation before use. During treatment, regular liver function tests and muscle-related tests should be conducted, and any abnormal symptoms should be reported to medical personnel immediately. This medication can interact with several drugs; therefore, patients should inform their doctor or pharmacist if they are taking other medications. Particular caution is needed when used in conjunction with certain antibiotics, antifungal agents, HIV medications, some antihypertensive drugs, and hypoglycemic agents. Women of childbearing age should use appropriate contraception during use and immediately discontinue use if pregnant. Nursing women should avoid using this medication, and special caution is necessary for children and elderly patients as well. There is no specific antidote for overdose; treatment should be symptomatic, and it should be stored out of reach of children.

Side effects

  • Weakness
  • lethargy
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • nasopharyngitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
Show 161 more
  • loss of appetite
  • constipation
  • abdominal bloating
  • dyspepsia
  • nausea
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pancreatitis
  • pharyngitis
  • laryngitis
  • epistaxis
  • insomnia
  • nightmares
  • headache
  • dizziness
  • paresthesia
  • sensory loss
  • taste disorder
  • amnesia
  • peripheral neuropathy
  • myalgia
  • arthralgia
  • limb pain
  • musculoskeletal pain
  • muscle cramps
  • joint swelling
  • back pain
  • neck pain
  • muscle fatigue
  • complications due to rupture
  • myopathy
  • myositis
  • rhabdomyolysis
  • tendon disorders
  • muscle rupture
  • lupus-like syndrome
  • immune-mediated necrotizing myopathy
  • thrombocytopenia
  • vasculitis
  • allergic reactions
  • anaphylaxis
  • hepatitis
  • cholestasis
  • liver failure
  • visual disturbances
  • visual impairment
  • tinnitus
  • hearing loss
  • urticaria
  • skin rash
  • itching
  • hair loss
  • angioedema
  • vascular neurogenic edema
  • erythema multiforme
  • mucocutaneous syndrome
  • toxic epidermal necrolysis
  • gynecomastia
  • abnormal liver function tests
  • increased serum CK
  • positive urinary leukocytes
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • increased TSH
  • increased ACTH
  • decreased aldosterone
  • increased potassium
  • elevated BUN
  • cerebral infarction
  • palpitations
  • tachycardia
  • vomiting
  • abdominal abnormalities
  • cholestasis
  • cholestatic jaundice
  • abnormal liver function test results
  • gastroenteritis
  • enteritis
  • dry mouth
  • rectal bleeding
  • esophagitis
  • glossitis
  • oral ulcers
  • stomatitis
  • gallbladder pain
  • cheilitis
  • gastric and duodenal ulcers
  • dysphagia
  • melena
  • gingival bleeding
  • postprandial urgency
  • bronchitis
  • rhinitis
  • pneumonia
  • dyspnea
  • asthma
  • sensory abnormalities
  • vertigo
  • phototoxic reactions
  • drowsiness
  • forgetfulness
  • abnormal dreams
  • decreased libido
  • anxiety
  • ataxia
  • torticollis
  • facial paralysis
  • hyperkinetic syndrome
  • depression
  • hypertension
  • myositis
  • muscle disease
  • arthritis
  • bursitis
  • tenosynovitis
  • myasthenia gravis
  • tendon contracture
  • elevated serum myoglobin
  • contact dermatitis
  • dry skin
  • sweating
  • acne
  • eczema
  • seborrhea
  • skin ulcers
  • erectile dysfunction
  • urinary tract infection
  • frequent urination
  • cystitis
  • hematuria
  • dysuria
  • kidney stones
  • nocturia
  • epididymitis
  • fibrocystic breast disease
  • vaginal bleeding
  • albuminuria
  • breast enlargement
  • cervical secretion
  • nephritis
  • urinary incontinence
  • urinary retention
  • urgency
  • abnormal ejaculation
  • uterine bleeding
  • discolored urine
  • hypothermia
  • hyperkinesia
  • sleep disorders
  • memory loss
  • depression
  • interstitial lung disease
  • sexual dysfunction
  • cognitive impairment
  • severe myasthenia
  • ocular myasthenia
  • elevated AST

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly closed container to protect it from air and moisture. The storage temperature should be kept between 1 degree and 30 degrees Celsius.

Appearance and packaging

Appearance

White round film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.